Literature DB >> 11284921

PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii.

G Bou1, G Cerveró, M A Domínguez, C Quereda, J Martínez-Beltrán.   

Abstract

OBJECTIVE: To demonstrate the usefulness of REP-PCR and AP-PCR on molecular typing of A. baumannii isolates.
METHOD: From February to November 1997, 29 inpatients at Ramón y Cajal Hospital, Madrid-23 in five intensive care units (ICUs) and six at two different medical departments-were either colonized or infected with imipenem- and meropenem-resistant Acinetobacter baumannii (IMRAB) strains (MICs of 64-256 mg/L). A wide antibiotic multiresistance profile was observed with IMRAB strains, and only tobramycin, sulbactam and colistin displayed valuable activity. For typing IMRAB isolates, repetitive extragenic palindromic sequence-based polymerase chain reaction (REP-PCR) and arbitrary primer sequence-based polymerase chain reaction (AP-PCR) methods were used and compared with pulsed-field gel electrophoresis (PFGE) as reference technique. For comparative purposes, 30 imipenem- and meropenem-susceptible A. baumannii (IMSAB) strains isolated before, during and after the outbreak were included in this study.
RESULTS: The molecular typing results showed that the outbreak was caused by a single IMRAB strain (genotype 1). On the other hand, seven different genotypes were observed in the pre-, at- and post-outbreak strains tested by REP-PCR. Regarding AP-PCR, three of four at-outbreak IMSAB strains were indistinguishable from the IMRAB profile. Thus, with AP-PCR, only six genotypes were obtained, apart from the IMRAB genotype.
CONCLUSION: Under our experimental conditions, REP-PCR had a higher discriminatory power than AP-PCR, with PFGE as reference technique. The REP-PCR technique is a useful and expeditious method for the epidemiologic characterization of A. baumannii nosocomial outbreaks, the results being comparable to those obtained with the PFGE technique.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11284921     DOI: 10.1046/j.1469-0691.2000.00181.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  40 in total

1.  Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii.

Authors:  Carlos Rumbo; Esteban Fernández-Moreira; María Merino; Margarita Poza; Jose Antonio Mendez; Nelson C Soares; Alejandro Mosquera; Fernando Chaves; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Molecular characterization of hand flora and environmental isolates in a community setting.

Authors:  Preeti Pancholi; Mimi Healy; Tracy Bittner; Renee Webb; Fan Wu; Allison Aiello; Elaine Larson; Phyllis Della Latta
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Sequence-based typing of ade B as a potential tool to identify intraspecific groups among clinical strains of multidrug-resistant Acinetobacter baumannii.

Authors:  Geert Huys; Margo Cnockaert; Alexandr Nemec; Jean Swings
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Characteristics of Streptococcus mutans genotypes and dental caries in children.

Authors:  Kyounga Cheon; Stephen A Moser; Howard W Wiener; Jennifer Whiddon; Stephanie S Momeni; John D Ruby; Gary R Cutter; Noel K Childers
Journal:  Eur J Oral Sci       Date:  2013-04-19       Impact factor: 2.612

5.  Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry.

Authors:  Joseph A Ecker; Christian Massire; Thomas A Hall; Raymond Ranken; Thuy-Trang D Pennella; Cristina Agasino Ivy; Lawrence B Blyn; Steven A Hofstadler; Timothy P Endy; Paul T Scott; Luther Lindler; Tacita Hamilton; Charla Gaddy; Kerry Snow; Marie Pe; Joel Fishbain; David Craft; Gregory Deye; Scott Riddell; Eric Milstrey; Bruno Petruccelli; Sylvain Brisse; Vanessa Harpin; Amy Schink; David J Ecker; Rangarajan Sampath; Mark W Eshoo
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system.

Authors:  Tara Reddy; Teena Chopra; Dror Marchaim; Jason M Pogue; George Alangaden; Hossein Salimnia; Dina Boikov; Shiri Navon-Venezia; Robert Akins; Philip Selman; Sorabh Dhar; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

7.  Comparison of in Vitro Activity of Doripenem versus Old Carbapenems against Pseudomonas Aeruginosa Clinical Isolates from both CF and Burn Patients.

Authors:  Zoya Hojabri; Mohammad Ahangarzadeh Rezaee; Mohammad Reza Nahaei; Mohammad Hossein Soroush; Morteza Ghojazadeh; Tahereh Pirzadeh; Mostafa Davodi; Mona Ghazi; Reza Bigverdi; Omid Pajand; Mohammad Aghazadeh
Journal:  Adv Pharm Bull       Date:  2013-02-07

Review 8.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  Emergence of Acinetobacter baumannii ST730 carrying the blaOXA-72 gene in Brazil.

Authors:  Mariana Pagano; Franciéli P Rozales; Diego Bertolini; Lisiane Rocha; Jorge Lm Sampaio; Afonso L Barth; Andreza F Martins
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-09       Impact factor: 2.743

10.  In vitro activity and in vivo efficacy of clavulanic acid against Acinetobacter baumannii.

Authors:  Alejandro Beceiro; Rafael López-Rojas; Juan Domínguez-Herrera; Fernando Docobo-Pérez; Germán Bou; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.